• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除的胃腺癌中EGFR、HER2和HER3蛋白表达的评估及预后分析

Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.

作者信息

Tang Daoqiang, Liu Charles Yj, Shen Danping, Fan Shuqiong, Su Xinying, Ye Peng, Gavine Paul R, Yin Xiaolu

机构信息

Department of Pathology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

Department of Translational Science, Asia and Emerging Market iMed, AstraZeneca R&D, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

出版信息

Onco Targets Ther. 2014 Dec 16;8:7-14. doi: 10.2147/OTT.S70922. eCollection 2015.

DOI:10.2147/OTT.S70922
PMID:25565860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4274138/
Abstract

AIM

To investigate the significance of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER)2, and HER3 expression on survival outcomes in Chinese gastric cancer patients.

MATERIALS AND METHODS

Formalin-fixed, paraffin-embedded specimens from 121 patients who underwent gastrectomy at Shanghai Renji Hospital from 2007-2010 were retrospectively examined. Fluorescence in situ hybridization and immunohistochemistry techniques were used to identify gene amplification and protein overexpression. Correlations between the expression or amplification of HER family genes and clinicopathological parameters were then determined using statistical analysis.

RESULTS

EGFR protein overexpression, an increase in HER2 copy number and gene amplification, and HER3 protein overexpression were identified in 33.1%, 17.4%, and 62.0% of samples, respectively. Statistical analysis showed a significant association between EGFR expression and tumor invasion depth or tumor stage. HER2 was also shown to be significantly associated with the tumor grade. In addition, EGFR protein overexpression was found to be significantly associated with worse overall survival (P=0.03).

CONCLUSION

The HER family members showed a high expression in gastric cancer. EGFR protein expression was associated with overall survival.

摘要

目的

探讨表皮生长因子受体(EGFR)、人表皮生长因子受体(HER)2和HER3表达对中国胃癌患者生存结局的意义。

材料与方法

回顾性研究2007年至2010年在上海仁济医院接受胃切除术的121例患者的福尔马林固定、石蜡包埋标本。采用荧光原位杂交和免疫组织化学技术鉴定基因扩增和蛋白过表达。然后使用统计分析确定HER家族基因表达或扩增与临床病理参数之间的相关性。

结果

分别在33.1%、17.4%和62.0%的样本中鉴定出EGFR蛋白过表达、HER2拷贝数增加和基因扩增以及HER3蛋白过表达。统计分析显示EGFR表达与肿瘤浸润深度或肿瘤分期之间存在显著关联。HER2也显示与肿瘤分级显著相关。此外,发现EGFR蛋白过表达与较差的总生存期显著相关(P = 0.03)。

结论

HER家族成员在胃癌中呈高表达。EGFR蛋白表达与总生存期相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/399381fc5ed6/ott-8-007Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/82605e0c1c83/ott-8-007Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/0e1f8b9c4c2f/ott-8-007Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/caf5851db0e6/ott-8-007Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/24a451db1283/ott-8-007Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/399381fc5ed6/ott-8-007Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/82605e0c1c83/ott-8-007Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/0e1f8b9c4c2f/ott-8-007Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/caf5851db0e6/ott-8-007Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/24a451db1283/ott-8-007Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e672/4274138/399381fc5ed6/ott-8-007Fig5.jpg

相似文献

1
Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.手术切除的胃腺癌中EGFR、HER2和HER3蛋白表达的评估及预后分析
Onco Targets Ther. 2014 Dec 16;8:7-14. doi: 10.2147/OTT.S70922. eCollection 2015.
2
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.表皮生长因子受体(EGFR)和蛋白激酶 B1(AKT1)过表达相互排斥,与胃腺癌切除术后不良生存相关。
Cancer Biomark. 2018 Feb 14;21(3):731-741. doi: 10.3233/CBM-170865.
3
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.评估曲妥珠单抗治疗转移性乳腺癌患者的所有四个 HER 家族受体的预后价值:希腊肿瘤协作组(HeCOG)研究。
PLoS One. 2018 Dec 6;13(12):e0207707. doi: 10.1371/journal.pone.0207707. eCollection 2018.
4
HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.希腊胃癌患者群体中HER家族蛋白表达情况。希腊合作肿瘤学组的一项回顾性研究。
Anticancer Res. 2016 Apr;36(4):1581-90.
5
Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.胃癌中表皮生长因子受体(HER)改变的预后意义:HER2 和 HER3 是不良预后的预测因子。
J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27.
6
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.HER家族mRNA表达在高危早期乳腺癌中的预后意义评估:一项希腊合作肿瘤学组(HeCOG)验证研究
J Transl Med. 2015 May 29;13:171. doi: 10.1186/s12967-015-0530-0.
7
Significance of HER2 protein expression and gene amplification in colorectal adenocarcinomas.HER2蛋白表达及基因扩增在结直肠癌中的意义
World J Gastrointest Oncol. 2019 Apr 15;11(4):335-347. doi: 10.4251/wjgo.v11.i4.335.
8
EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.表皮生长因子受体(EGFR)家族与c-Met在食管胃腺癌中的表达谱及预后意义
J Gastrointest Oncol. 2016 Dec;7(6):838-847. doi: 10.21037/jgo.2016.06.09.
9
EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.表皮生长因子受体(EGFR)基因扩增相对常见,且与胃、胃食管交界和食管远端的肠型腺癌的预后相关。
BMC Cancer. 2016 Jul 7;16:406. doi: 10.1186/s12885-016-2456-1.
10
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.表皮生长因子受体在非小细胞肺癌中的临床意义及 HER2 基因拷贝数在女性患者中的预后作用。
J Thorac Oncol. 2010 Oct;5(10):1536-43. doi: 10.1097/JTO.0b013e3181ea510a.

引用本文的文献

1
Beyond Detection: Conventional and Emerging Biomarkers in Gastrointestinal Cancers.超越检测:胃肠道癌症中的传统生物标志物与新兴生物标志物
Cancers (Basel). 2025 Aug 22;17(17):2725. doi: 10.3390/cancers17172725.
2
Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma.HER2/EGFRvIII/CD44与Claudin 18.2/CD109共表达作为胃腺癌新的预后指标
World J Oncol. 2025 Jun;16(3):254-268. doi: 10.14740/wjon2552. Epub 2025 Apr 4.
3
Investigating the Co-Expression Rate of HER2 and HER3 Biomarkers in Cancer Patients: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.胃腺癌患者大样本中 HER2、EGFR、MET 和 FGFR2 的表达谱。
Gastric Cancer. 2015 Apr;18(2):227-38. doi: 10.1007/s10120-014-0360-4. Epub 2014 Mar 14.
2
HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.原发性结直肠癌患者及其相应淋巴结转移中 HER3 的表达与临床结局的关系。
Eur J Cancer. 2014 Feb;50(3):656-62. doi: 10.1016/j.ejca.2013.11.008. Epub 2013 Nov 30.
3
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.
探讨癌症患者 HER2 和 HER3 生物标志物的共表达率:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):2979-2990. doi: 10.31557/APJCP.2024.25.9.2979.
4
HER2 becomes a novel survival biomarker for gastric cancer patients: a pooled analysis.HER2成为胃癌患者一种新的生存生物标志物:一项汇总分析。
Ther Adv Med Oncol. 2024 Sep 5;16:17588359241271913. doi: 10.1177/17588359241271913. eCollection 2024.
5
A Comprehensive Review of HER2 in Cancer Biology and Therapeutics.HER2 在癌症生物学和治疗学中的全面综述。
Genes (Basel). 2024 Jul 11;15(7):903. doi: 10.3390/genes15070903.
6
Correlation between the overexpression of epidermal growth factor receptor and pathological features of gastric cancer: a meta-analysis.表皮生长因子受体过表达与胃癌病理特征的相关性:一项荟萃分析。
Transl Cancer Res. 2021 Jan;10(1):406-416. doi: 10.21037/tcr-20-2035.
7
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy.采用液相电子显微镜技术定量分析过表达 HER2 的乳腺癌细胞中的 EGFR-HER2 异二聚体。
Cells. 2021 Nov 19;10(11):3244. doi: 10.3390/cells10113244.
8
Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer.表皮生长因子受体(EGFR)在转移性胃/胃食管交界癌治疗中的治疗意义
Front Oncol. 2020 Aug 4;10:1312. doi: 10.3389/fonc.2020.01312. eCollection 2020.
9
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers.对多种人类上皮癌具有强效抗癌作用的新型功能性抗HER3单克隆抗体。
Oncotarget. 2020 Jan 7;11(1):31-45. doi: 10.18632/oncotarget.27414.
10
Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer.表皮生长因子受体家族及其在胃癌中的作用。
Front Oncol. 2019 Nov 26;9:1308. doi: 10.3389/fonc.2019.01308. eCollection 2019.
食管腺癌中 HER-2/neu 基因扩增与 HER2 和 HER3 蛋白表达的关系。
Cancer. 2014 Feb 1;120(3):415-24. doi: 10.1002/cncr.28435. Epub 2013 Oct 21.
4
EGFR tyrosine kinase inhibitors: difference in efficacy and resistance.表皮生长因子受体酪氨酸激酶抑制剂:疗效和耐药性的差异。
Curr Oncol Rep. 2013 Aug;15(4):396-404. doi: 10.1007/s11912-013-0323-7.
5
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.第 7 版 AJCC 分期分类对 NCCN 肿瘤学胃癌和食管癌临床实践指南的影响。
J Natl Compr Canc Netw. 2013 Jan 1;11(1):60-6. doi: 10.6004/jnccn.2013.0009.
6
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.表达人类表皮生长因子受体 EGFR 和 ERBB2 对 II/III 期胃癌患者生存的影响。
Clin Cancer Res. 2012 Nov 1;18(21):5992-6000. doi: 10.1158/1078-0432.CCR-12-1318. Epub 2012 Sep 12.
7
ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer.表皮生长因子受体酪氨酸激酶/NF-κB 信号通路调控人乳腺癌的肿瘤球形成。
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6584-9. doi: 10.1073/pnas.1113271109. Epub 2012 Apr 5.
8
Improving treatment of HER2-positive cancers: opportunities and challenges.改善 HER2 阳性癌症的治疗:机遇与挑战。
Sci Transl Med. 2012 Mar 28;4(127):127rv2. doi: 10.1126/scitranslmed.3001539.
9
Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.与 HER2 阳性胃癌相关的临床病理因素及其对生存结果的影响——系统评价。
Int J Cancer. 2012 Jun 15;130(12):2845-56. doi: 10.1002/ijc.26292. Epub 2011 Nov 17.
10
Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.胃癌中表皮生长因子受体(HER)改变的预后意义:HER2 和 HER3 是不良预后的预测因子。
J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27.